Mozart Therapeutics is Developing Disease Modifying Therapies

Описание: Mozart is focused on developing disease-modifying therapies for patients with #autoimmune and #inflammatory diseases. They aim to reset and restore the balance of the #immune system by modulating a novel regulatory network. Katie Fanning, CEO of Mozart Therapeutics, gives insights into the company’s business model and highlights the importance of collaboration to achieve #breakthroughs in #science.

Subscribe to our channel for more on breakthroughs in health and agriculture:
https://bit.ly/2PJvazz

Connect with us:
https://leaps.bayer.com/
  / leapsbybayer  
  / leapsbybayer  
  / leapsbybayer  

About Mozart Therapeutics:
Mozart is focused on developing disease-modifying therapies for autoimmune and inflammatory diseases. They aim to reset and restore the balance of the immune system by leveraging a novel pathway to develop first-in-class CD8 Treg modulators to delay onset, reduce severity and potentially reverse the course of disease that allow patients to lead normal lives.

Learn more:
https://bit.ly/3tVJVDi

About us:
Leaps by Bayer invests in paradigm-shifting advances in the life sciences – targeting the breakthroughs that could fundamentally change the world for the better. Our approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity.